Emerging Oral Atypical Antipsychotics Will Garner Only Limited Uptake in the … - PR Newswire (press release)
The Pharmacor 2010 findings from the topic entitled Schizophrenia reveals that emerging oral atypical antipsychotics such as Merck's Saphris/Sycrest
Источник: